329 related articles for article (PubMed ID: 11874629)
1. Interleukin 6 induces overexpression of the sarcolemmal utrophin in neonatal mdx skeletal muscle.
Fujimori K; Itoh Y; Yamamoto K; Miyagoe-Suzuki Y; Yuasa K; Yoshizaki K; Yamamoto H; Takeda S
Hum Gene Ther; 2002 Mar; 13(4):509-18. PubMed ID: 11874629
[TBL] [Abstract][Full Text] [Related]
2. Immune response to adenovirus-delivered antigens upregulates utrophin and results in mitigation of muscle pathology in mdx mice.
Yamamoto K; Yuasa K; Miyagoe Y; Hosaka Y; Tsukita K; Yamamoto H; Nabeshima YI; Takeda S
Hum Gene Ther; 2000 Mar; 11(5):669-80. PubMed ID: 10757347
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of dystrophin and utrophin gene transfer in immunocompetent muscular dystrophy (mdx) mice.
Ebihara S; Guibinga GH; Gilbert R; Nalbantoglu J; Massie B; Karpati G; Petrof BJ
Physiol Genomics; 2000 Sep; 3(3):133-44. PubMed ID: 11015608
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological activation of PPARbeta/delta stimulates utrophin A expression in skeletal muscle fibers and restores sarcolemmal integrity in mature mdx mice.
Miura P; Chakkalakal JV; Boudreault L; Bélanger G; Hébert RL; Renaud JM; Jasmin BJ
Hum Mol Genet; 2009 Dec; 18(23):4640-9. PubMed ID: 19744959
[TBL] [Abstract][Full Text] [Related]
5. Expression of full-length utrophin prevents muscular dystrophy in mdx mice.
Tinsley J; Deconinck N; Fisher R; Kahn D; Phelps S; Gillis JM; Davies K
Nat Med; 1998 Dec; 4(12):1441-4. PubMed ID: 9846586
[TBL] [Abstract][Full Text] [Related]
6. [Development of new therapy on muscular dystrophy].
Takeda S
Rinsho Shinkeigaku; 2001 Dec; 41(12):1154-6. PubMed ID: 12235824
[TBL] [Abstract][Full Text] [Related]
7. iNOS expression in dystrophinopathies can be reduced by somatic gene transfer of dystrophin or utrophin.
Louboutin JP; Rouger K; Tinsley JM; Halldorson J; Wilson JM
Mol Med; 2001 May; 7(5):355-64. PubMed ID: 11474581
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice.
Rafael JA; Tinsley JM; Potter AC; Deconinck AE; Davies KE
Nat Genet; 1998 May; 19(1):79-82. PubMed ID: 9590295
[TBL] [Abstract][Full Text] [Related]
9. Transgenic overexpression of dystroglycan does not inhibit muscular dystrophy in mdx mice.
Hoyte K; Jayasinha V; Xia B; Martin PT
Am J Pathol; 2004 Feb; 164(2):711-8. PubMed ID: 14742274
[TBL] [Abstract][Full Text] [Related]
10. Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy.
D'Arcy CE; Feeney SJ; McLean CA; Gehrig SM; Lynch GS; Smith JE; Cowling BS; Mitchell CA; McGrath MJ
Hum Mol Genet; 2014 Feb; 23(3):618-36. PubMed ID: 24087791
[TBL] [Abstract][Full Text] [Related]
11. Efficient utrophin expression following adenovirus gene transfer in dystrophic muscle.
Gilbert R; Nalbanoglu J; Tinsley JM; Massie B; Davies KE; Karpati G
Biochem Biophys Res Commun; 1998 Jan; 242(1):244-7. PubMed ID: 9439643
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice.
Nguyen HH; Jayasinha V; Xia B; Hoyte K; Martin PT
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5616-21. PubMed ID: 11960016
[TBL] [Abstract][Full Text] [Related]
13. Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.
Guiraud S; Edwards B; Squire SE; Moir L; Berg A; Babbs A; Ramadan N; Wood MJ; Davies KE
Hum Mol Genet; 2019 Jan; 28(2):307-319. PubMed ID: 30304405
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy.
Chaubourt E; Fossier P; Baux G; Leprince C; Israël M; De La Porte S
Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 and neuregulin-1 as regulators of utrophin expression via the activation of NRG-1/ErbB signaling pathway in mdx cells.
Juretić N; Díaz J; Romero F; González G; Jaimovich E; Riveros N
Biochim Biophys Acta Mol Basis Dis; 2017 Mar; 1863(3):770-780. PubMed ID: 27988307
[TBL] [Abstract][Full Text] [Related]
16. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
17. [Utrophin, a way to cure Duchenne muscle dystrophy].
Gillis JM
Med Sci (Paris); 2004 Apr; 20(4):442-7. PubMed ID: 15124117
[TBL] [Abstract][Full Text] [Related]
18. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice.
Porter JD; Merriam AP; Khanna S; Andrade FH; Richmonds CR; Leahy P; Cheng G; Karathanasis P; Zhou X; Kusner LL; Adams ME; Willem M; Mayer U; Kaminski HJ
FASEB J; 2003 May; 17(8):893-5. PubMed ID: 12670877
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with induced chronic inflammation in mdx skeletal muscle cause posttranslational stabilization and augmentation of extrasynaptic sarcolemmal utrophin.
Waheed I; Gilbert R; Nalbantoglu J; Guibinga GH; Petrof BJ; Karpati G
Hum Gene Ther; 2005 Apr; 16(4):489-501. PubMed ID: 15871680
[TBL] [Abstract][Full Text] [Related]
20. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer.
Cerletti M; Negri T; Cozzi F; Colpo R; Andreetta F; Croci D; Davies KE; Cornelio F; Pozza O; Karpati G; Gilbert R; Mora M
Gene Ther; 2003 May; 10(9):750-7. PubMed ID: 12704413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
